Ace the CPHON Challenge 2026 – Elevate Your Pediatric Oncology Nursing Game!

The appropriate action to take before transfusing blood products to individuals with Cold Antibody Autoimmune Hemolytic Anemia (AIHA) is to wash and warm the blood products. This is essential because patients with cold antibody AIHA have antibodies that react at colder temperatures, potentially causing hemolysis of transfused blood if it is not properly managed.

Washing the blood products removes plasma proteins that could provoke an immune response and helps to reduce the risk of hemolysis. Warming the blood products helps to ensure that they are at a temperature that is less likely to activate the cold antibodies, allowing for safer transfusion and minimizing the risk of adverse reactions.

In contrast, irradiating blood products is generally done to prevent graft-versus-host disease and is not specifically indicated for cold antibody AIHA. Storing products at room temperature or exposing them to light does not address the issues presented by cold antibodies and could lead to complications if the blood is not kept at the appropriate temperature before transfusion.